Department of Veterans Affairs (VA)

Concerns mount over depression drug Spravato as VA approval looms

A recently approved drug for treatment-resistant depression was branded as a wonder drug, but serious questions have been raised about its approval process, effectiveness and safety, the Center for Public Integrity reports.

Why it matters: "For veterans whose ranks are plagued by depression and suicides, much is at stake," CPI writes. "A drug that offers [a] fast and lasting answer for treatment-resistant depression would be a godsend. But is this drug the answer?"

Seth Moulton tackles mental health with 2020 treatment plan

Rep. Seth Moulton
Rep. Seth Moulton. Photo: Michael Brochstein/SOPA Images/LightRocket/Getty Images

Rep. Seth Moulton (D-Mass.) sought treatment for post-traumatic stress disorder after serving as a Marine in the Iraq War, and the experience prompted him to reveal a military mental health plan as part of his 2020 presidential campaign, Politico reports.

"I had some particular experiences or regrets from the war that I just thought about every day, and occasionally I’d have bad dreams or wake up in a cold sweat. But because these experiences weren’t debilitating — I didn’t feel suicidal or completely withdrawn, and I was doing fine in school — it took me a while to appreciate that I was dealing with post-traumatic stress and I was dealing with an experience that a lot of other veterans have."
— Rep. Seth Moulton told Politico